Skip to Main Content

Advertisement

Close

About the Press
For Librarians
Rights & Permissions
Books Open External Link
Job Board Open External Link
JCB Journal of Cell Biology
JEM Journal of Experimental Medicine
JGP Journal of General Physiology
JHI Journal of Human Immunity
LSA Open External Link Life Science Alliance

JCB

JEM

JGP

JHI

LSA

header search

search input Search input auto suggest

filter your search

Search

Advanced Search

Menu

Articles
Reviews & Opinion
Collections
Email Alerts
About
Submit
Job BoardOpen External Link

Skip Nav Destination

Article| December 01 1986

Correction

Author and Article Information

Online ISSN: 1540-9538

Print ISSN: 0022-1007

1986

J Exp Med (1986) 164 (6): 2131.

https://doi.org/10.1084/jem.164.6.2131

Standard View
Views
Open the PDF for in another window
Share
- Facebook
- X
- LinkedIn
- Email
- Bluesky
Tools
- Get Permissions
- Cite
Search Site

Citation

Correction . J Exp Med 1 December 1986; 164 (6): 2131. doi: https://doi.org/10.1084/jem.164.6.2131

Download citation file:

Ris (Zotero)
Reference Manager
EasyBib
Bookends
Mendeley
Papers
EndNote
RefWorks
BibTex

toolbar search

toolbar search

search input Search input auto suggest

filter your search

Search

Advanced Search

This content is only available as a PDF.

1986

Article PDF first page preview

First page of Correction

First page of Correction

Related & Metrics

Data & Figures

Contents

Volume 164, Issue 6

1 December 1986

Journal of Experimental Medicine Cover Image for Volume 164, Issue 6

Previous Article

Supplements

References

Related & Metrics

44 Views

View Metrics

Suggested Content

T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity.

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.

Email alerts

Complete Issue Alert

Daily Publication Alert

Advertisement

Newest Articles
Current Issue
Archive
Alerts

Submit a Manuscript
Instructions for Authors
For Librarians
About JEM

Editors & Staff
Policies & Permissions
Accessibility Statement
Cookie Policy

Terms & Conditions
Advertise
Contact Us
Newsroom

Privacy Policy
RSS Feeds

Facebook
X/Twitter
Instagram
YouTube
LinkedIn
Bluesky

© 2025 Rockefeller University Press

Online ISSN 1540-9538
Print ISSN 0022-1007

This Feature Is Available To Subscribers Only

Sign In or Create an Account